News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Viva Biotech And HQL Pharmaceuticals Join Forces To Form Powerhouse For Structure - And Fragment - Based Drug Discovery


3/5/2014 9:21:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SHANGHAI & REHOVOT, Israel.--(BUSINESS WIRE)--Viva Biotech Ltd., a leading company in structure-based and fragment based drug discovery services, based in Shanghai, China, and HQL Pharmaceuticals Ltd., a drug discovery company utilizing its super-power proprietary ChemSpace Scanner (CSS™) computational technology, based in Rehovot, Israel, today announced that they have entered into a strategic alliance to jointly provide a fully-integrated drug discovery services, focused on leads generation based on fragment screening.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com
Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES